From Grassroots to Class III Level A Hospitals | Shanghai Sun Biotech Demonstrates the Full Scenario of Coagulation Diagnosis

On March 24, 2025, the 22nd China International Exhibition on Laboratory Medicine and Transfusion Instruments and Reagents (CACLP) successfully concluded at the Hangzhou Grand Exhibition Center. Shanghai Sun Biotech participated in the exhibition with a full range of instruments and reagent products for thrombosis and hemostasis diagnosis, attracting the attention of many industry experts and partners, and fully demonstrating its 25 years of technical accumulation and innovation capabilities in the field of coagulation diagnosis.

New Product Launch: Coagulation Detection Enters a New Stage of Multifunctional Integration

At the new product launch conference on the first day of the exhibition, the UG2500 coagulation analyzer launched by Shanghai Sun Biotech became the focus of attention. By integrating the detection of coagulation function and platelet aggregation function, the UG2500 solves the pain point of the separation of the evaluation of the first-stage and second-stage hemostatic functions in clinical practice, providing more comprehensive laboratory data support for preoperative diagnosis, anticoagulant therapy monitoring, and blood disease management. This instrument combines the dual advantages of the optical method and the magnetic bead method for coagulation detection, and can intelligently switch the detection mode according to the sample situation, minimizing the interference of severely hemolyzed, icteric, and lipemic (HIL) samples and the usage cost; its trace detection mode is more suitable for pediatric patients and those with difficult blood collection, further expanding the clinical application scenarios.

A number of new thrombosis and hemostasis diagnostic reagent products launched simultaneously, including protein C/S, lupus anticoagulant, anti-factor Xa, and eight coagulation factor detection reagents, mark that Shanghai Sun Biotech has established a complete product line from basic coagulation screening to the detection of special items such as thrombophilia diagnosis, antiphospholipid syndrome detection, and anticoagulant therapy monitoring, filling a number of domestic product gaps.

Meeting Multi-level Demands: The Matrix of Coagulation Analyzers Debuts in the Roadshow

In the roadshow session of star products, Shanghai Sun Biotech comprehensively demonstrated its complete lineup of coagulation diagnosis products, highlighting its ability to meet the diverse needs of medical institutions at different levels

UL-2000LAS Coagulation Detection Line:It integrates the ultra-high-speed UR8000 analysis module (900 tests per hour) and the intelligent and compact pre-processing unit (occupying an area of<2m2), supports AI sample quality identification, sample single-tube RFID wireless radio frequency tracking and on-orbit sampling, is compatible with online emergency and single-machine emergency priority sampling, and provides an efficient and intelligent solution for large hospitals.

UR8000 Coagulation Analyzer:As the world's first ultra-high-speed coagulation analyzer, the UR8000, with a detection efficiency of 900 tests per hour, combined with the intelligent task scheduling system, has a comprehensive efficiency increased by 260% compared with traditional equipment, meeting the needs of high-intensity detection.

UR6000 Constant-speed Coagulation Analyzer: With a constant-speed detection of 450 tests per hour, it supports three modes of front sample injection, side sample injection, and production line sample injection. It has functions such as automatic 360° code scanning of sample tubes, closed-cap puncture, and automatic APTT correction, adapting to the detection needs of medium and high-end hospitals.

UP5500 Constant-speed Coagulation Analyzer:With a constant-speed detection of 420 tests per hour, HIL monitoring and multi-wavelength anti-interference technology, and automatic APTT correction function, it significantly improves the detection accuracy and efficiency of middle-level medical institutions.

The Full Product Line Layout Takes Shape, Covering Multi-level Medical Demands

With the promotion of the integration of medical resources and the hierarchical diagnosis and treatment system, medical institutions at different levels have obvious differentiated demands in coagulation detection. Grassroots medical institutions have a relatively small number of detection samples and usually offer routine coagulation screening items; while large general hospitals have concentrated patients and a large number of samples. In addition to routine screening, they often carry out the detection of special items such as thrombophilia, lupus anticoagulant, coagulation factors, and anticoagulant drug monitoring to precisely guide clinical diagnosis and treatment. Relying on its complete product layout, Shanghai Sun Biotech can fully meet the detection needs of medical institutions at different levels.

Full Range of High, Medium, and Low-speed Coagulation Analyzers

The company's coagulation analyzer product line covers multiple gradients of high, medium, and low speeds: low-speed models UP1500 and UP3000, medium and high-speed models UG2500, UP5500, and UR6000, as well as ultra-high-speed models UR8000 (900 tests per hour) and UL-2000LAS fully automatic coagulation line. The complete instrument matrix precisely matches the different throughput requirements from grassroots medical institutions to Class III hospitals.

Comprehensive Coagulation Detection Menu from Routine to Special Items

The launch of this series of new reagent products marks the comprehensive improvement of the company's thrombosis and hemostasis detection item system: it covers a complete set of detection items from basic screening (PT, APTT, TT, FIB, etc.), to the diagnosis of bleeding and thrombotic diseases (three items for thrombophilia, lupus anticoagulant, eight coagulation factors, etc.), and treatment monitoring (anti-factor Xa activity), providing a full-process solution for clinical practice from initial screening, diagnosis to treatment monitoring, and meeting the multi-dimensional detection needs of medical institutions at different levels.

Shanghai Sun Biotech will continue to deepen technological innovation, adhere to the concept of "creating products for life", and promote the high-quality development of the field of thrombosis and hemostasis diagnosis.

About Shanghai SunBio

Founded in 2001, Shanghai Sun Biotech Co.,Ltd. specializes in the field of thrombosis and hemostasis diagnostics and is a leading global provider of comprehensive solutions in this domain. Guided by the philosophy of “Creating Products for Life,” the company is dedicated to the development, manufacturing, and sales of thrombosis and hemostasis diagnostic reagents, medical instruments, and medical consumables.

Shanghai SunBio upholds strict quality management standards and has obtained dual international certifications for ISO 9001 and ISO 13485. The company's core products hold independent intellectual property rights, with more than 100 patents in total. Additionally, SunBio actively participates in the formulation of national industry standards for PT, APTT, TT, FIB, D-Dimer, anti-Xa, and coagulation analyzers, contributing to the standardization of coagulation testing technologies. Recognized for its innovation and excellence, Shanghai SunBio has been awarded prestigious titles such as The Ministry of Industry and Information Technology (MIIT) “Little Giant” Enterprise, National High-Tech Enterprise, Shanghai Science and Technology 'Little Giant' Enterprise, and one of Shanghai’s Top 100 Smart Factories.

Looking ahead, Shanghai SunBio will continue to deepen its expertise in thrombosis and hemostasis diagnostics, driving product advancements through technological innovation, continually providing professional coagulation diagnostic solutions for global customers, and supporting the sustainable development of the healthcare industry worldwide.